Different patterns of heparin resistance:: therapeutic implications

被引:58
作者
Ranucci, M
Isgrò, G
Cazzaniga, A
Ditta, A
Boncilli, A
Cotza, M
Carboni, G
Brozzi, S
机构
[1] Univ Milan, Ist Policlin S Donato, Cardiovasc Ctr E Malan, Dept Cardiothorac Anaesthesia, Milan, Italy
[2] Univ Milan, Ist Policlin S Donato, Cardiovasc Ctr E Malan, Dept Cardiovasc Perfus, Milan, Italy
来源
PERFUSION-UK | 2002年 / 17卷 / 03期
关键词
D O I
10.1191/0267659102pf562oa
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heparin resistance (HR) during cardiac operations is a common feature. Its aetiology often recognizes a decrease in circulating antithrombin III (AT III) due to a preoperative heparin treatment. Nevertheless, some papers highlighted the existence of HR in patients with normal values of AT III. This paper was designed in order to identify this subgroup of AT III-independent heparin-resistant patients. Five hundred consecutive patients scheduled for coronary revascularization with cardiopulmonary bypass were enrolled in this prospective trial. HR was identified in 104 (20.8%) patients. Thirty-six of them (7.2% of the total population) had a preoperative AT III activity greater than or equal to100%, and were defined as AT III-independent heparin-resistant patients. This subgroup significantly differs from the AT Ill-dependent heparin-resistant group being affected by a less severe degree of HR and including less patients pretreated with heparin. Unlike the other heparin-resistant patients, these subjects do not respond to AT III supplementation aimed at reaching supranormal AT III activity values.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 22 条
[1]  
BEGUIN S, 1992, THROMB HAEMOSTASIS, V68, P136
[2]   EXCESSIVE REQUIREMENT FOR HEPARIN DURING CARDIAC-SURGERY [J].
CHUNG, F ;
DAVID, TE ;
WATT, J .
CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1981, 28 (03) :280-282
[3]  
CLOYD GM, 1987, J THORAC CARDIOV SUR, V94, P535
[4]   METABOLISM OF ANTITHROMBIN-3 (HEPARIN COFACTOR) IN MAN - EFFECTS OF VENOUS THROMBOSIS AND OF HEPARIN ADMINISTRATION [J].
COLLEN, D ;
SCHETZ, J ;
DECOCK, F ;
HOLMER, E ;
VERSTRAETE, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (01) :27-35
[5]   ANTI-THROMBIN-III IN PATIENTS TREATED WITH SUBCUTANEOUS OR INTRAVENOUS HEPARIN [J].
CONARD, J ;
LECOMPTE, T ;
HORELLOU, MH ;
CAZENAVE, B ;
SAMAMA, M .
THROMBOSIS RESEARCH, 1981, 22 (04) :507-511
[6]  
Despotis GJ, 1996, THROMB HAEMOSTASIS, V76, P902
[7]  
DIETRICH W, 1991, J THORAC CARDIOV SUR, V102, P505
[8]  
ESPOSITO RA, 1983, J THORAC CARDIOV SUR, V85, P346
[9]  
Gravlee G P, 1987, J Cardiothorac Anesth, V1, P379, DOI 10.1016/S0888-6296(87)96676-2
[10]   HEPARIN AND ANTITHROMBIN-III LEVELS DURING CARDIOPULMONARY BYPASS - CORRELATION WITH SUBCLINICAL PLASMA COAGULATION [J].
HASHIMOTO, K ;
YAMAGISHI, M ;
SASAKI, T ;
NAKANO, M ;
KUROSAWA, H .
ANNALS OF THORACIC SURGERY, 1994, 58 (03) :799-804